Nimbus Therapeutics is a biotechnology company focused on discovering and developing clinically meaningful small molecule medicines with high target specificity. Based in Boston, Massachusetts, the company emphasizes design with intentionality across people, targets, and molecules to advance oncology, immunology, and metabolic indications. Nimbus highlights world-class expertise and leading-edge technologies to drive translational medicine and clinical development, aiming to improve patients’ lives. The organization has a track record of success in developing targeted, selective therapies.
No recent deals for this company.